January 26, 2012
Speaking at a seminar held by Astellas Pharma and Pfizer Japan on January 25, Prof. Naoki Ishiguro of the Department of Orthopedic Surgery, Nagoya University Graduate School of Medicine predicted that demand for the non-steroidal anti-inflammatory drug (NSAID) Celecox (celecoxib),...read more